Results 11 to 20 of about 1,436,982 (204)
Nonmotor Symptoms in a Malaysian Parkinson’s Disease Population [PDF]
Background. The nonmotor symptoms are important determinants of health and quality of life in Parkinson’s disease but are not well recognized and addressed in clinical practice.
Shahrul Azmin +7 more
doaj +5 more sources
Nonmotor symptoms in dystonia: Pathophysiological implications [PDF]
Anumeha Mishra, Sanjay Pandey
doaj +4 more sources
The Impact of Nonmotor Symptoms on Health-Related Quality of Life in Parkinson’s Disease: A Network Analysis Approach [PDF]
Nonmotor symptoms negatively affect health-related quality of life (HRQoL) in patients with Parkinson’s disease (PD). However, it is unknown which nonmotor symptoms are most commonly associated with HRQoL.
Diego Santos, Tino Prell, Pablo Mir
exaly +4 more sources
Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy [PDF]
Objectives. To explore the clinical correlates of nonmotor symptoms (NMS) in progressive supranuclear palsy (PSP) and their differences from healthy controls and patients with Parkinson’s disease (PD). Methods.
Ruwei Ou +7 more
doaj +5 more sources
Nonmotor symptoms in Parkinson’s disease patients in South Asia: A systematic review and meta-analysis [PDF]
Background: The most common movement disorder and neurodegenerative disorder that progresses over time, Parkinson’s disease, has both motor and nonmotor symptoms. Asia is home to half of the world’s elderly population, and Parkinson’s disease is a common
Prayash Paudel, Asutosh Sah
doaj +2 more sources
Background. Frequently used nonmotor scales do not cover all aspects of dysautonomia in Parkinson’s disease (PD). This study explores the association between autonomic symptoms and sicca symptoms with other nonmotor symptoms and health-related quality of
Tino Prell +4 more
doaj +2 more sources
Nonmotor symptoms in genetic Parkinson disease [PDF]
To review current knowledge on nonmotor symptoms (NMS), particularly psychiatric features, in genetic Parkinson disease (PD) and to provide original data for genetic and idiopathic ...
Johann Hagenah +31 more
core +4 more sources
Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms
Background: Addition of catechol-O-methyltransferase inhibitors to a conventional levodopa/dopadecarboxylase inhibitor regimen improves motor symptoms in patients with Parkinson’s disease.
Thomas Müller,
doaj +2 more sources
Ceruloplasmin in Parkinson's disease and the nonmotor symptoms [PDF]
AbstractObjectivesTo investigate the relationship between ceruloplasmin (CP) and Parkinson's disease (PD), and the correlation between CP level and the time difference between nonmotor symptoms and motor symptoms and the diagnosis were also mentioned.Materials and MethodsSixty‐six patients diagnosed with PD for the first time were included in the study.
Zunjing Liu, Ziqiang Shao, Yu Zhang
exaly +5 more sources
Nonmotor symptoms are an integral part of Parkinson’s disease and cause significant morbidity. Pharmacological therapy helps alleviate the disease but produces nonmotor manifestations.
Rupam Borgohain +3 more
doaj +3 more sources

